EsoCap Biotech
Switzerland, CH · 2 known investors
Find your way into EsoCap Biotech
5 people in our graph share verified history with the EsoCap Biotech team — schools, employers, funds. One of them is your warm intro.
David Delbourgounlockedknows Isabelle Racamier · together at Genomic Vision (overlapped)
×4knows the team · via Genomic Vision
EsoCap AG is a clinical-stage Swiss biotech company developing treatments for esophageal diseases. The company is led by an experienced industry team with clinical development expertise.
Founders & leadership
PD
Prof. Dr. Werner WeitschiesFounder and Chief Scientific Advisor
IR

Isabelle RacamierCEOIsabelle Racamier is CEO of EsoCap Biotech, a clinical-stage biotech company developing treatments for esophageal diseases, and brings experience in clinical development, regulatory programs, and capital raising across European, US, and Asian markets.
Board
WT
Werner TschollarChairman of the Board
Investors · 2
Frequently asked questions
- What does EsoCap Biotech do?
- EsoCap AG is a clinical-stage Swiss biotech company developing treatments for esophageal diseases. The company is led by an experienced industry team with clinical development expertise.
- Who founded EsoCap Biotech?
- EsoCap Biotech was founded by Prof. Dr. Werner Weitschies.
- Who are EsoCap Biotech's investors?
- EsoCap Biotech's investors include CARELA Holding GmbH, sandstorm.vc.
- Where is EsoCap Biotech headquartered?
- EsoCap Biotech is headquartered in Switzerland, CH.

